Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Vanderbilt-Ingram Cancer Center
NRG Oncology
National Institutes of Health Clinical Center (CC)
University of Arizona
H. Lee Moffitt Cancer Center and Research Institute
Rise Therapeutics LLC
University of Virginia
Providence Health & Services
University of Pittsburgh
M.D. Anderson Cancer Center
Hookipa Biotech GmbH
Cancer Research UK
German Cancer Research Center
Revolution Medicines, Inc.
UNICANCER
Pfizer
Advaxis, Inc.
Center for Biomedical Research, Inc.
Revolution Medicines, Inc.
Becton, Dickinson and Company
Seagen Inc.
Leiden University Medical Center
Jiangxi Provincial Cancer Hospital
Revolution Medicines, Inc.
University of Alabama at Birmingham
National Institutes of Health Clinical Center (CC)
Blokhin's Russian Cancer Research Center
McMaster University
MultiVir, Inc.
University of Chicago
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Kansas Medical Center
Anandasabapathy, Sharmila, M.D.
Sesen Bio, Inc.
Sesen Bio, Inc.
Duke University
Merck KGaA, Darmstadt, Germany
Access Pharmaceuticals, Inc.
AHS Cancer Control Alberta
M.D. Anderson Cancer Center
AstraZeneca
AstraZeneca
Ministry of Scientific Research and Information Technology, Poland